ReviewDiabetology international2025

Comparing the anorexigenic effects and mechanisms of gut-derived GLP-1 and its receptor agonists: insights into incretin-based therapies for obesity.

Yuta Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.